182 related articles for article (PubMed ID: 11595625)
21. Cytotoxic necrotizing factor type 2 produced by pathogenic Escherichia coli deamidates a gln residue in the conserved G-3 domain of the rho family and preferentially inhibits the GTPase activity of RhoA and rac1.
Sugai M; Hatazaki K; Mogami A; Ohta H; Pérès SY; Hérault F; Horiguchi Y; Masuda M; Ueno Y; Komatsuzawa H; Suginaka H; Oswald E
Infect Immun; 1999 Dec; 67(12):6550-7. PubMed ID: 10569774
[TBL] [Abstract][Full Text] [Related]
22. Rho/ROCK-dependent inhibition of 3T3-L1 adipogenesis by G-protein-deamidating dermonecrotic toxins: differential regulation of Notch1, Pref1/Dlk1, and β-catenin signaling.
Bannai Y; Aminova LR; Faulkner MJ; Ho M; Wilson BA
Front Cell Infect Microbiol; 2012; 2():80. PubMed ID: 22919671
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxic necrotizing factor 1 from Escherichia coli: a toxin with a new intracellular activity for eukaryotic cells.
Boquet P
Folia Microbiol (Praha); 1998; 43(3):285-9. PubMed ID: 9717256
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic necrotizing factor 1 of Escherichia coli stimulates Rho/Rho-kinase-dependent myosin light-chain phosphorylation without inactivating myosin light-chain phosphatase in endothelial cells.
Essler M; Linder S; Schell B; Hüfner K; Wiedemann A; Randhahn K; Staddon JM; Aepfelbacher M
Infect Immun; 2003 Sep; 71(9):5188-93. PubMed ID: 12933863
[TBL] [Abstract][Full Text] [Related]
25. Bacterial toxins activating Rho GTPases.
Munro P; Lemichez E
Curr Top Microbiol Immunol; 2005; 291():177-90. PubMed ID: 15981464
[TBL] [Abstract][Full Text] [Related]
26. Identification of functional domains of Bordetella dermonecrotizing toxin.
Kashimoto T; Katahira J; Cornejo WR; Masuda M; Fukuoh A; Matsuzawa T; Ohnishi T; Horiguchi Y
Infect Immun; 1999 Aug; 67(8):3727-32. PubMed ID: 10417130
[TBL] [Abstract][Full Text] [Related]
27. Exchange of a single amino acid switches the substrate properties of RhoA and RhoD toward glucosylating and transglutaminating toxins.
Jank T; Pack U; Giesemann T; Schmidt G; Aktories K
J Biol Chem; 2006 Jul; 281(28):19527-35. PubMed ID: 16702216
[TBL] [Abstract][Full Text] [Related]
28. Bordetella dermonecrotic toxin binds to target cells via the N-terminal 30 amino acids.
Fukui-Miyazaki A; Ohnishi S; Kamitani S; Abe H; Horiguchi Y
Microbiol Immunol; 2011 Mar; 55(3):154-9. PubMed ID: 21204952
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of small Rho GTPases by the multifunctional RTX toxin from Vibrio cholerae.
Sheahan KL; Satchell KJ
Cell Microbiol; 2007 May; 9(5):1324-35. PubMed ID: 17474905
[TBL] [Abstract][Full Text] [Related]
30. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine.
Flatau G; Lemichez E; Gauthier M; Chardin P; Paris S; Fiorentini C; Boquet P
Nature; 1997 Jun; 387(6634):729-33. PubMed ID: 9192901
[TBL] [Abstract][Full Text] [Related]
31. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion.
Doye A; Mettouchi A; Bossis G; Clément R; Buisson-Touati C; Flatau G; Gagnoux L; Piechaczyk M; Boquet P; Lemichez E
Cell; 2002 Nov; 111(4):553-64. PubMed ID: 12437928
[TBL] [Abstract][Full Text] [Related]
32. Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells.
Lerm M; Selzer J; Hoffmeyer A; Rapp UR; Aktories K; Schmidt G
Infect Immun; 1999 Feb; 67(2):496-503. PubMed ID: 9916051
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic necrotizing factor-2 of Escherichia coli alters the morphology of cultured hippocampal neurons.
Boutillier S; Rapp J; Staeb T; Olenik C; Schmidt G; Meyer DK; Leemhuis J
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):513-9. PubMed ID: 14605794
[TBL] [Abstract][Full Text] [Related]
34. Structural elements required for deamidation of RhoA by cytotoxic necrotizing factor 1.
Buetow L; Ghosh P
Biochemistry; 2003 Nov; 42(44):12784-91. PubMed ID: 14596592
[TBL] [Abstract][Full Text] [Related]
35. Deamidation of RhoA glutamine 63 by the Escherichia coli CNF1 toxin requires a short sequence of the GTPase switch 2 domain.
Flatau G; Landraud L; Boquet P; Bruzzone M; Munro P
Biochem Biophys Res Commun; 2000 Jan; 267(2):588-92. PubMed ID: 10631106
[TBL] [Abstract][Full Text] [Related]
36. Rho GTPases as targets of bacterial protein toxins.
Aktories K; Schmidt G; Just I
Biol Chem; 2000; 381(5-6):421-6. PubMed ID: 10937872
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the dermonecrotic toxin in members of the genus Bordetella.
Walker KE; Weiss AA
Infect Immun; 1994 Sep; 62(9):3817-28. PubMed ID: 8063398
[TBL] [Abstract][Full Text] [Related]
38. Strategies for the structural determination of the catalytic domain of Escherichia coli cytotoxic necrotizing factor 1.
Buetow L; Flatau G; Chiu K; Boquet P; Ghosh P
Acta Crystallogr D Biol Crystallogr; 2002 Feb; 58(Pt 2):366-9. PubMed ID: 11807279
[TBL] [Abstract][Full Text] [Related]
39. Response from Emmanuel Lemichez: A new turn in Rho GTPase activation by Escherichia coli cytotoxic necrotizing factors.
Lemichez E
Trends Microbiol; 2003 Apr; 11(4):156. PubMed ID: 12706989
[No Abstract] [Full Text] [Related]
40. Production of Highly Active Recombinant Dermonecrotic Toxin of
Stanek O; Linhartova I; Holubova J; Bumba L; Gardian Z; Malandra A; Bockova B; Teruya S; Horiguchi Y; Osicka R; Sebo P
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32942577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
